IBM Audit Myths That Cost Buyers Money
Misconceptions about IBM audits lead buyers to over comply, over pay, and surrender defensible positions. Here are five of the most expensive myths, and the buyer side reality behind each.
Myth: the audit is just routine paperwork
An audit is a revenue motion, not an administrative formality. The appointed auditor is measuring for findings, and IBM expects a commercial result. Treating it as routine is how buyers return unscoped data and accept the first number presented.
Myth: ILMT being installed means you are compliant
Installing ILMT is necessary, not sufficient. Sub-capacity eligibility requires the tool deployed within 90 days, running continuously, with quarterly reports retained for two years, and with installs classified correctly. A broken agent or a miscategorized install voids the sub-capacity claim for that period and can default you to full-capacity charging.
Myth: you must return everything IBM requests
You must meet your contractual audit obligations, but that is not the same as returning every raw export on demand. The data response can be scoped to the contractual right, validated for accuracy, and curated before it leaves. What you send sets the ceiling on the claim.
Myth: the findings are final
Findings are an opening position. On average, challenges land 30 to 50% of findings. Wrong PVU values, denied sub-capacity, and missing entitlement offsets are all disputable with evidence. Accepting the report as final leaves money on the table by default.
Myth: you cannot negotiate the renewal during an audit
The audit and the renewal are the same negotiation. IBM often proposes to fold exposure into a new agreement. That is the moment to protect forward pricing and secure favorable terms, not to concede them and negotiate separately later.
Every one of these myths pushes the buyer toward compliance theater and away from leverage. The findings are contestable, the data is scopable, and the renewal is part of the same negotiation, right up to signature.